Qube Research & Technologies LTD Poseida Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$3.08 - $8.73 $736,612 - $2.09 Million	239,160 Added 629.24%	277,168 $853,000
Q4 2022 Feb 14, 2023	BUY	$3.33 - $6.38 $46,340 - $88,784	13,916 Added 57.76%	38,008 $201,000
Q3 2022 Nov 14, 2022	SELL	$2.43 - $4.51 $8,006 - $14,860	-3,295 Reduced 12.03%	24,092 $85,000
Q2 2022 Aug 15, 2022	BUY	$1.87 - $5.0 $51,213 - $136,935	27,387 New	27,387 $71,000
Q4 2020 Feb 16, 2021	SELL	$8.29 - $11.7 $85,461 - $120,615	-10,309 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.09 - $16.25 $83,399 - $167,521	10,309 New	10,309 $91,000

38.5M

377K

22.2K

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $810M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.